Results 31 to 40 of about 4,684,794 (400)

Anticoagulation after typical atrial flutter ablation [PDF]

Клиническая практика, 2023
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial ...
Irina A. Bulavina, Igor A. Khamnagadaev, Igor I. Khamnagadaev, Mikhail L. Kokov, Aleksandr V. Troitskiy, Aleksandr S. Zotov, Leonid S. Kokov, Maria A. Shkolnikova   +7 more
doaj   +1 more source

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

Annals of Neurology, 2020
It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed.
D. Seiffge, G. M. De Marchis, M. Koga, M. Paciaroni, D. Wilson, M. Cappellari, Kosmas Macha, G. Tsivgoulis, G. Ambler, S. Arihiro, L. Bonati, B. Bonetti, B. Kallmünzer, K. Muir, P. Bovi, H. Gensicke, M. Inoue, S. Schwab, S. Yaghi, Martin M. Brown, P. Lyrer, Masahito Takagi, Monica Acciarrese, H. Jager, A. Polymeris, K. Toyoda, M. Venti, C. Traenka, H. Yamagami, A. Alberti, S. Yoshimura, V. Caso, S. Engelter, D. Werring   +33 more
semanticscholar   +1 more source

Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis.

Blood, 2020
Treatment of splanchnic vein thrombosis (SVT) is challenging and evidence to guide therapeutic decisions remains scarce. The objective of this systematic review and meta-analysis was to determine the efficacy and safety of anticoagulant therapy for SVT ...
Emanuele Valeriani, M. Di Nisio, Nicoletta Riva, O. Cohen, J. García‐Pagán, M. Magaz, E. Porreca, W. Ageno   +7 more
semanticscholar   +1 more source

Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)

Frontiers in Neurology, 2021
Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.Methods: This ...
Pål Rønning, Eirik Helseth, Eirik Helseth, Ola Skaansar, Cathrine Tverdal, Cathrine Tverdal, Nada Andelic, Nada Andelic, Rahul Bhatnagar, Mathias Melberg, Nils Oddvar Skaga, Mads Aarhus, Sigrun Halvorsen, Sigrun Halvorsen, Ragnhild Helseth   +14 more
doaj   +1 more source

Self-regulated hirudin delivery for anticoagulant therapy

Science Advances, 2020
Polymeric nanogel with on-demand release of hirudin prevents and inhibits clot formation. Pathological coagulation, a disorder of blood clotting regulation, induces a number of cardiovascular diseases.
Xiao Xu, Xuechao Huang, Ying Zhang, Shiyang Shen, Zhizi Feng, He Dong, Can Zhang, Ran Mo   +7 more
semanticscholar   +1 more source

Anticoagulant therapy for splanchnic vein thrombosis

Journal of Thrombosis and Haemostasis, 2020
1Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands 2Department of Medicine and Ageing Sciences, “G. D'Annunzio” University, Chieti-Pescara, Italy 3Department of Medical, Oral and Biotechnological Sciences, “G.
M. Di Nisio, Emanuele Valeriani, Nicoletta Riva, S. Schulman, J. Beyer-Westendorf, W. Ageno   +5 more
semanticscholar   +1 more source

Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

BMC Family Practice, 2021
Background Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs).
Shera Chaterji, Lay Geok Lian, Ting Yee Lee, Liwei Chua, Sabrina Yi-Mei Wee, Sui Ling Yap, Dhana Letchimy K, Ngiap Chuan Tan   +7 more
doaj   +1 more source

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Mutiara Medika, 2022
Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis.
Agus Fitriyanto Achmad, Yuni Iswati Raharjani, Zidni Setyaningrum, Bagus Andi Pramono, Dita Ria Selvyana, Sri Pramesthi Wisnu Bowo Negoro   +5 more
doaj   +1 more source

Clinical audit of anticoagulant therapy with pregnancy

Al-Azhar Assiut Medical Journal, 2020
Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy ...
Mahmoud I El-Rasheedy, Ahmed H Mohammed, Asmaa M Mahmoud   +2 more
doaj   +1 more source

Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report [PDF]

, 2017
The treatment with fondaparinux is the effective and safe anticoagulant therapy in liver transplant patient on immunosuppressive therapy with arterial thrombosis, and it seems able to reduce liver fibrosis.
Cafolla, Arturo, Gentile, Giuseppe
core   +1 more source